Using secosteroids to treat skin cancer caused by UVB exposure
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
This study is looking at a new treatment for skin cancer caused by UVB rays, using special compounds that might help slow down cancer growth and heal the skin, so patients can have better options for their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Birmingham VA Medical Center NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11010771 on NIH RePORTER |
What this research studies
This research investigates the potential of secosteroids derived from CYP11A1 as therapeutic agents for skin cancer that develops due to UVB radiation. The approach focuses on understanding how these compounds can inhibit cancer cell growth and promote healing in affected skin. Patients may benefit from new treatment options that target the underlying mechanisms of UVB-induced skin cancer, potentially leading to improved outcomes. The methodology includes laboratory studies and possibly clinical trials to evaluate the effectiveness of these secosteroids in real-world scenarios.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals diagnosed with skin cancer related to UVB exposure.
Not a fit: Patients with skin cancer not related to UVB exposure or those with other unrelated skin conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new therapeutic options for patients suffering from UVB-induced skin cancer.
How similar studies have performed: While the use of secosteroids in this specific context is novel, there have been other studies exploring similar therapeutic approaches with promising results.
Where this research is happening
Birmingham, United States
- Birmingham VA Medical Center — Birmingham, United States (Active)
Researchers
- Principal investigator: Slominski, Andrzej T — Birmingham VA Medical Center
- Study coordinator: Slominski, Andrzej T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.